An open clinical study to evaluate the clinical efficacy of Siddha sasthric formulation UTHAMANI KARUKKU for the treatment of KANA MAANTHAM.

An open clinical study to evaluate the clinical efficacy of siddha sasthric formulation UTHAMANI KARUKKU in the treatment of KANA MAANTHAM.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014544

Enrollment

Registered

2018-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K522- Allergic and dietetic gastroenteritis and colitis Health Condition 2: null- Kana Maantham

Interventions

Intervention1: Uthamani karukku: 65mg BD with hot water for 7 days. Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Weight loss Cough Fever Watery nasal discharge Headache Diarrhea Bloating abdomen Drowsiness

Exclusion criteria

Exclusion criteria: Protein Energy Malnutrition Mesentric Adenitis Tubercular enteritis Peritonitis Severe dehydration

Design outcomes

Primary

Measure	Time frame
To evaluate and standardize therapeutic management of kana Maantham with Uthamani Karukku.Timepoint: 1 year	—

Secondary

Measure	Time frame
To determine the prognosis of Kana Maantham based on Sidhha principles.Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDrDKSoundararajan

Government Siddha Medical College and Hospital

easwaridhanapathy@gmail.com9094463987

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026